What percentage of Type II diabetes patients will eventually require insulin therapy?

Type II diabetes is a progressive condition, meaning that over time, the body's ability to produce insulin can diminish. While lifestyle changes and oral medications can effectively manage the disease for many individuals initially, a significant percentage will eventually reach a point where their blood glucose levels can no longer be adequately controlled without the use of insulin therapy.

Research and clinical data suggest that around 30% of individuals with Type II diabetes will require insulin therapy as their disease advances. This need for insulin is often due to the gradual decline in pancreatic function and insulin secretion capabilities, as well as the body's increased resistance to insulin. By 10 to 15 years after diagnosis, the reliance on insulin becomes more prevalent, emphasizing the progressive nature of the disease and the importance of ongoing monitoring and adjustment in treatment plans. Therefore, understanding that approximately one-third of Type II diabetes patients will eventually need insulin helps healthcare providers in planning and managing long-term care for these individuals.